絞り込み

16515

広告

「Breast Cancer Res Treat[Journal]」の検索結果

8473件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.

Metastatic Breast Cancer Collateral Damage Project (MBCCD): Scale development and preliminary results of the Survey of Health, Impact, Needs, and Experiences (SHINE).

Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer.

Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer.

Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants.

Effect of glucocorticoid use on survival in patients with stage I-III breast cancer.

Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database.

Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.

The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway.

Predictors of surveillance mammography outcomes in women with a personal history of breast cancer.

Gene expression in triple-negative breast cancer in relation to survival.

Associations of dietary intake and supplement use with post-therapy cognitive recovery in breast cancer survivors.

Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy.

Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer.

Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database.

Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologists.

SNP rs2071095 in LincRNA H19 is associated with breast cancer risk.

Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016).

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります